6. Griesofulvin
• Used orally
• Ineffective topically
• For dermatophytes
• not useful for systemic infections
• Steptomyces griesofulvum
• Disrupts mitotic spindle
• Never given in empty stomach
• Increased absorption with fat
• Enzyme inducers (azoles are inhibitors)
• S/E
• disulfiram like reaction
TONY SCARIA 2010 KMC
7. Amphotericin B
• Polyene antifungal
• Fungicidal at higher concentration &
fungistatic at lower concentration
• Binds to ergosterol forms pores in cell
membrane increases permeability
TONY SCARIA 2010 KMC
8. AMB
• Widest antifungal spectrum
• Not absorbed orally used topically
• USED ONLY IV
BROADEST AZOLE POSACONAZOLE
TONY SCARIA 2010 KMC
9. S/E of AMB
• Nephrotoxicity
• Dose limiting S/E nephrotoxicity
• Nephrotoxicity can be decreased by
• saline loading of AMB
• Lipid bound IV preparations
• Amphotericin B lipid complex
• Amphotericin B colloidal suspension
• Liposomal AMB
• Nephrotoxicity increased by
• Volume depletion
• Concomitant administration of other nephrotoxic drugs Aminoglycosides
TONY SCARIA 2010 KMC
10. AMB IS INCORPORATED IN TO LIPOSOME
BILAYER
• TARGETED DRUG DELIVERY
• AMB IN LIPOSOME IS BROKEN DOWN IN ANOXIC CONDITIONS ONLY
• Is broken down only in regions with fungal infection
TONY SCARIA 2010 KMC
11. Other S/E of AMB
• Allergic manifestation
• Decreased by intake of steroids + NSAIDS
• Hypokalemia d/t renal failure
• Hypomagnesemia
• Anemia
TONY SCARIA 2010 KMC
12. S/e of AMB
• Azotemia
• Reduced GFR
• Hypokalemia
• Inability to concentrate urine
• Renal tubular acidosis
• Anemia
• Headache
• Vomiting
• Cranial nerve palsy TONY SCARIA 2010 KMC
13. During AMB monitor
• CBC
• s creatinine
• Serum K+
• Serum Mg2+
TONY SCARIA 2010 KMC
14. • AMB is safe during pregnancy
• Dose is reduced when combined with 5 FC
TONY SCARIA 2010 KMC
15. AMB is also used for
• Kala azar
• Cryptococcus
TONY SCARIA 2010 KMC
16. Other polyene antifungals (like AMB)
• Nystatin
• Hamycin
• Natamycin
Used topically
TONY SCARIA 2010 KMC
17. Flucytosine
• Orally with amphotericin B for
systemic infection
• AMB causes pores in membrane +
flucytosine enters through pores &
inhibit DNA synthesis
• Used in conjuction with AMB in
cryptococcal meningitis
• S/E
• Bonemarrow suppression
TONY SCARIA 2010 KMC
19. Ketoconazole
• Maintenance drug;
• Given by oral route
• Inhibits lanosterol-danosterol synthesis
• pH dependent absorption; avoided with antacids
• Absorption inhibited by PPI ,H2 blockers, antacids
• Inhibits CYP enzymes
• T_1/2 ^= 24 hours
• Rx-recurrent moniliasis
• Topically, used for dandruff
• Hepatitis-serious side effect
• Antiandrogenic
• Decrease androgen production from testes
• Displaces testosterone from protein binding sites gynaecomastia/ loss of libido/
TONY SCARIA 2010 KMC
29. Echinocandins
• Activity against candida & invasive aspergillosis
• Disadv
• No oral form
• Not effective against Cryptococcus mucormycosis histoplasmosis
• Very low CNS penetration
TONY SCARIA 2010 KMC